Albert
Also known as Albert Invent, Albert Invent Corp.
Software and AI for chemistry and materials R&D at chemical and consumer-goods companies: it captures experiments, structures the data and lets scientists search and reason over it, suggest formulations and design experiments.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-10-13Series BRound
$55M
For: expand its chemistry AI capabilities to shorten customers' development cycles
Models and platform
The company's Business Wire release, read in full in its Yahoo Finance copy. It gives no valuation and no cumulative total; the legal name is Albert Invent Corp.
Lead · TCVDelta-v CapitalSocium VenturesHighSage VenturesCoral CapitalLegion VCExisting investor · CoatueExisting investor · J.P. Morgan Growth Equity PartnersExisting investor · Index VenturesExisting investor · Applied Ventures
On the deal: Morgan Gerlak (Partner; spoke for the lead in the announcement, TCV)
Announced by the company · albertinvent.com ↗On the timeline →
- 2024-12-11Series ARound
$22.5M
For: not stated in the report read; announced with the launch of its Breakthrough AI product
Not stated
TechCrunch quotes CEO Nick Talken; the company's own release was not read. It says a small seed round led by Index Ventures came in late 2022. A growth round led by J.P. Morgan in February 2025 is not recorded: its amount was not read at source.
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Index VenturesChai Discovery, Cradle, Inherent, Ineffable Intelligence
- F-PrimeXaira Therapeutics, Owkin, Insilico Medicine
- CoatueIambic Therapeutics
- Socium VenturesEnveda